Vaxcyte, Inc. — Director's Dealing 2023

Nov 29, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2023-11-27

Reporting Person: Lee Jacks (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-27	Stock Option (Right to Buy)	$50.13	A	30000	Acquired	2033-11-26	Common Stock (30000)	Direct

Footnotes

F1: Option shall vest over 36 months, 1/3 of which will vest on November 27, 2024 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.